Abstract
In order to study differences in antigen expression related to the different stages of the process of metastasis of human melanoma cell lines, we determined the expression pattern of a series of well-characterized genes in a set of human melanoma cell lines with different metastatic behavior in nude mice. This set included non-metastatic (IF6, 530), sporadically metastatic (M14, Mel 57), and frequently metastatic (BLM, MV3) cell lines after subcutaneous inoculation. To study the phenotype of these cell lines both the cultured cells and representative samples of local tumors at the inoculation site and their metastases in the lungs were immunostained with a panel of monoclonal antibodies directed against melanocytic differentiation or progression antigens. Although most cell lines (IF6, 530, M14 and Mel 57) showed HLA-DR expressionin vitro, these antigens were lacking in all xenografted lesions studied with exception of the 530 cell line. 530 Xenografts, however, showed a dramatic down-regulation of HLA-DR compared with the cell linein vitro. The same phenomenon was seen with respect to ICAM-1 expression. The expression of all other antigens studied in xenografts, both in subcutaneous tumors and in lung lesions, was in general comparable to that in the melanoma cell linesin vitro, with exception of the 530 cell line. In all melanoma cell lines except 530 the degree of intra- and interlesional heterogeneity regarding the expression of all antigens studied was limited. Remarkably, comparison of the immunophenotype of the frequently metastasizing (BLM, MV3) and the sporadically (M14, Mel 57) or non-metastasizing (IF6, 530) cell lines showed that the two frequently metastasizing cell lines had marked expression of the progression antigens VLA-2 and epidermal growth factor receptor, and lack of expression of the differentiation antigen NKI-beteb. These findings warrant further studies on the role of these antigens in the process of metastasis of human melanoma cells in nude mice.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Balkwill, F. R., Stevens, M. H., Griffin, D. B., Thomas, J. A., andBodmer, J. G., 1987, Interferon gamma regulates HLA-D expression on solid tumorsin vivo.European Journal of Cancer and Clinical Oncology,23, 101–106.
Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Millstein, C., Williams, A. F., andZiegler, A., 1978, Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.Cell,14, 9–20.
Bröcker, E.-B., Suter, L., Brüggen, J., Ruiter, D. J., Macher, E., andSorg, C., 1985, Phenotypic dynamics of tumor progression in human malignant melanoma.International Journal of Cancer,36, 29–35.
Brüggen, J., andSorg, C., 1983, Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies.Cancer Immunology and Immunotherapy,15, 200–205.
Brüggen, J., Sorg, C., andMacher, E., 1978, Membrane-associated antigens of human malignant melanoma: serological typing of cell lines using antisera from nonhuman primates.Cancer Immunology and Immunotherapy,5, 53–68.
Defize, L. H. K., Moolenaar, W. H., van der Saag, P. T., andde Laat, S. W., 1986, Dissociation of cellular responses to epidermal growth factor using antireceptor monoclonal antibodies.EMBO Journal,5, 1187–1192.
De Vries, J. E., Keizer, G. D., Te Velde, A. A., Voordouw, A., Ruiter, D., Rümke, Ph., Spits, H., andFigdor, C. G., 1986, Characterization of melanomaassociated surface antigens involved in the adhesion and motility of human melanoma cells.International Journal of Cancer,38, 465–473.
Elder, D. E., Rodeck, U., Thurin, J., Cardillo, F., Clark, W. H., Stewart, R., andHerlyn, M., 1989, Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.Cancer Research,49, 5091–5096.
Groenewegen, G., De Ley, M., Jeunhomme, G. M. A. A., andBuurman, W. A., 1986, Supernatants of human leukocytes contain mediator, different from interferon, which induces expression of MHC Class II antigens.Journal of Experimental Medicine,164, 131–143.
Hanna, N., andFidler, I. J., 1981, Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice.Cancer Research,41, 438–444.
Herlyn, M., Guerry, D., andKoprowski, H., 1985, Recombinant γ-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.Journal of Immunology,134, 4226–4230.
Holzmann, B., Bröcker, E.-B., Lehmann, J. M., Ruiter, D. J., Sorg, C., RiethmOller, G., andJohnson, J. P., 1987, Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes.International Journal of Cancer,30, 466–471.
Honsik, C. J., Diamant, M., andOlsson, L., 1986, Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment.Cancer Research,46, 940–949.
Houghton, A. N., Thomson, T. M., Gross, D., Oettgen, H. F., andOld, L. J., 1984, Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.Journal of Experimental Medicine,160, 255–269.
Johnson, J. P., Demmer-Dieckmann, M., Meo, T., Hadam, M. R., andRiethmüller, G., 1981, Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse origin.European Journal of Immunology,11, 825–831.
Johnson, J. P., Stade, B. G., Holzmann, B., Schwäble, W., andRiethmüller, G., 1989,De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.Proceedings of the National Academy of Sciences of the United States of America,86, 641–644.
Katano, M., Saxton, R. E., Cochran, A. J., andIrie, R. F., 1984, Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice.Journal of Cancer Research and Clinical Oncology,108, 197–203.
Kerbel, R. S., Waghorne, C., Korczak, B., Lagarde, A., andBreitman, M. L., 1988, Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications.Cancer Surveys,7, 597–629.
Klein, C. E., Steinmayer, T., Kaufmann, D., Bröcker, E.-B., 1990, Identification of a melanoma cell surface antigen which is associated with tumor progression as integrin VLA-2.Journal of Investigative Dermatology,95, 475.
Kyriazis, A. A., andKyriazis, A. P., 1980, Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation.Cancer Research,40, 4509–4511.
Lehmann, J. M., Holzmann, B., Breitbart, E. W., Schmiegelow, P., RiethmOller, G., andJohnson, J. P., 1987, Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight at 113,000 and a protein with a molecular weight of 70,000.Cancer Research,47, 841–845.
Lehmann, J. M., Sers, C., Riethmüller, G., andJohnson, J. P., 1989, cDNA cloning of two closely related melanoma glycoproteins: Muc 18 a marker for tumor progression and Muc 18 rep a new member of the immunoglobulin superfamily.Human Tumor Antigens and Specific Tumor Therapy, edited by R. Metzger and M. Mitchell (New York: Alan Liss), pp. 45–52.
Lemonnier, F. A., Rebai, N., LeBouteiller, Ph. P., Malissen, B., Caillol, D. H., andKourilsky, F. M., 1982, Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay.Journal of Immunological Methods,54, 9–22.
Lockshin, A., Giovanella, B. C., De Ipolyi, P. D., Williams, L. J. Jr, Mendoza, J. T., Yim, S. O., andStehlin, J. S. Jr, 1985, Exceptional lethality for nude mice of cells derived from a primary human melanoma.Cancer Research,45, 345–350.
Maio, M., Gulwani, B., Langer, J. A., Kerbel, L. S., Duigou, G. J., Fisher, P. B., andFerrone, S., 1989, Modulation by interferons of HLA antigen, highmolecular-weight melanoma-associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.Cancer Research,49, 2980–2987.
Matsui, M., Temponi, M., andFerrone, S., 1987, Characterization of a mono-clonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.Journal of Immunology,139, 2088–2095.
Nakane, P. K., andPierce, G. B., 1966, Enzyme-labeled antibodies: preparation and application for the localization of antigens.Journal of Histochemistry and Cytochemistry,14, 929–935.
Natali, P. G., Bigotti, A., Cavalieri, R., Nicotra, M. R., Teicce, R., Manfredi, D., Chen, Y.-X., Nadler, R. M., andFerrone, S., 1986, Gene products of the HLA-D region in normal and malignant tissues of non lymphoid origin.Human Immunology,15, 220–232.
Rodolfo, M., Balsari, A., Clémente, C., Parmiani, G., andFossati, G., 1988, Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice.Invasion and Metastasis,8, 317–331.
Ruiter, D. J., Dingjan, G. M., Steijlen, P. M., van Beveren-Hooyer, M., de Graaff-Reitsma, C. B., Bergman, W., van Muijen, G. N. P., andWarnaar, S. O., 1985, Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.Journal of Investigative Dermatology,85, 4–8.
Ruiter, D. J., van Muijen, G. N. P., van Nouhuys, H., andFerrone, S., 1990, Immunopathology of melanoma with monoclonal antibodies.Human Melanoma, edited by S. Ferrone (New York: Springer Verlag), pp. 253–277.
Suter, L., Brüggen, J., Bröcker, E.-B., andSorg, C., 1985, A tumor-associated antigen expressed in melanoma cells with lower malignant potential.International Journal of Cancer,35, 787–791.
Temponi, M., Romano, G., D'Urso, C. M., Wang, Z., Kekish, U., andFerrone, S., 1988, Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines.Seminars in Oncology,15, 595–607.
Van Duinen, S. G., Ruiter, D. J., Bröcker, E.-B., Van der Velde, E. A., Sorg, C., Welvaart, K., andFerrone, S., 1988, Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.Cancer Research,48, 1019–1025.
Van Muijen, G. N. P.,Jansen, K. F. J.,Cornelissen, L. M. H. A.,Smeets, D. F. C. M.,Beck, J. L. M., andRuiter, D. J., 1991, Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice.International Journal of Cancer, 47, in press.
Van Muijen, G. N. P., Ruiter, D. J., Hoefakker, S., andJohnson, J. P., 1990, Monoclonal antibody PAL-MI recognizes the transferrin receptor and is a progression marker in melanocytic lesions.Journal of Investigative Dermatology,95, 65–69.
Vennegoor, C., Hageman, Ph., van Nouhuys, H., Ruiter, D. J., Calafat, J., Ringens, P. J., andRumke, Ph., 1988, A monoclonal antibody specific for cells of the melanocyte lineage.American Journal of Pathology,130, 179–192.
Versteeg, R., Noodermeer, I. A., Krüse-Wolters, M., Ruiter, D. J., andSchrier, P. I., 1988, c-myc Down-regulates class I HLA expression in human melanomas.EMBO Journal,7, 1023–1029.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Muijen, G.N.P., Cornelissen, L.M.H.A., Jansen, C.F.J. et al. Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metast 9, 259–272 (1991). https://doi.org/10.1007/BF01753729
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01753729